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Can radical parametrectomy be omitted 
in occult cervical cancer after extrafascial 
hysterectomy?
Huai‑Wu Lu, Jing Li, Yun‑Yun Liu, Chang‑Hao Liu, Guo‑Cai Xu, Ling‑Ling Xie, Miao‑Fang Wu and Zhong‑Qiu Lin*
Abstract 
Background: Occult invasive cervical cancer discovered after simple hysterectomy is not common, radical parame‑
trectomy (RP) is a preferred option for young women. However, the morbidity of RP was high. The aim of our study 
is to assess the incidence of parametrial involvement in patients who underwent radical parametrectomy for occult 
cervical cancer or radical hysterectomy for early‑stage cervical cancer and to suggest an algorithm for the triage of 
patients with occult cervical cancer to avoid RP.
Methods: A total of 13 patients with occult cervical cancer who had undergone RP with an upper vaginectomy and 
pelvic lymphadenectomy were included in this retrospective study. Data on the clinicopathologic characteristics of 
the cases were collected. The published literature was also reviewed, and low risk factors for parametrial involvement 
in early‑stage cervical cancer were analyzed.
Results: Of the 13 patients, 9 had a stage IB1 lesion, and 4 had a stage IA2 lesion. There were four patients with 
grade 1 disease, seven with grade 2 disease, and two with grade 3 disease. The median age of the entire patients was 
41 years. The most common indication for extrafascial hysterectomy was cervical intraepithelial neoplasia 3. Three 
patients had visible lesions measuring 10–30 mm, in diameter and ten patients had cervical stromal invasions with 
depths ranging from 4 to 9 mm; only one patient had more than 50% stromal invasion, and four patients had lymph‑
vascular space invasion (LVSI). Perioperative complications included intraoperative bowel injury, blood transfusion, 
vesico‑vaginal fistula, and ileus (1 case for each). Postoperative pathologic examination results did not show residual 
disease or parametrial involvement. One patient with positive lymph nodes received concurrent radiation therapy. 
Only one patient experienced recurrence.
Conclusions: Perioperative complications following RP were common, whereas the incidence of parametrial involve‑
ment was very low among selected early‑stage cervical cancer patients. Based on these results, we thought that 
patients with very low‑risk parametrial involvement(tumor size ≤2 cm, no LVSI, less than 50% stromal invasion, nega‑
tive lymph nodes) may benefit from omitting RP. Further prospective data are warranted.
Keywords: Radical parametrectomy, Occult cervical cancer, Parametrial involvement, Perioperative complications
© 2015 Lu et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Occult invasive cervical cancer discovered after extrafas-
cial hysterectomy is rare. Without any further therapy, 
the 5-year survival rate of patients with occult invasive 
cervical cancer is less than 50% [1]. The treatment of 
occult invasive cervical cancer includes (1) adjuvant radi-
ation therapy [2, 3] or (2) radical parametrectomy which 
usually performed with upper vaginectomy and pelvic 
lymphadenectomy [4–6]. However, no prospective ran-
domized controlled trials have compared the efficacy of 
these two treatments due to the limited number of cases. 
Radiation therapy frequently results in bladder, rectal, 
and sexual dysfunction and, particularly, loss of ovarian 
function. In young women, RP is usually recommended, 
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because a negative pathology finding indicates no need 
for further therapy [7]. At the same time, the incidence of 
operative complications increase with the performance 
of radical parametrectomy, with reported rates as high as 
30%. The complications include intraoperative blood loss, 
blood transfusion, incidental cystostomy, and postopera-
tive ileus [8]. In cervical cancer surgery, individualization 
of treatment to reduce therapy-associated morbidity is 
the most current trend. Several retrospective studies in 
recent years have shown that the incidence of parame-
trial involvement is very low in selected patients [9–15]; 
therefore, it is likely unnecessary to perform parametrec-
tomy in these patients. The purpose of this study was to 
identify a subgroup of patients at low risk for parametrial 
involvement who may not require RP for occult cervical 
cancer.
Patients and methods
Thirteen patients who underwent radical parametrec-
tomy (RP) with upper vaginectomy and pelvic lym-
phadenectomy in the Department of Gynecology of Sun 
Yat-sen Memorial Hospital between July 2013 and Jan 
2005 were included in this study. All of the patients had 
been referred to our department after prior total hys-
terectomies at other hospitals. Prior to undergoing RP, 
informed consent was obtained from all patients.
The patients who met the following criteria were con-
sidered eligible for RP: (1) a normal pelvic examination 
before surgery and (2) no evidence of residual lesions on 
the vaginal cuff. Furthermore, samples from the extra-
fascial hysterectomy were pathologically reviewed to 
exclude patients with micro-invasive lesions (IA1) or 
patients with cancer involving the hysterectomy mar-
gin. Preoperative evaluations with magnetic resonance 
imaging (MRI) or computed tomography (CT) were per-
formed to exclude lymph node involvement.
Clinicopathologic data were collected, including demo-
graphics, indications for first surgery, tumor stage, review 
of the prior surgical specimen’s pathology, presence of 
lymph-vascular space invasion (LVSI), nodal status, oper-
ative complications, duration of indwelling catheteriza-
tion, residual urine volume, duration of hospital stay, 
recurrence, and survival. Follow-up data were obtained 
by medical record review or by patient correspondence.
Results
Clinicopathologic characteristics of patients at the initial 
operation
The median age of the 13 patients was 41  years (range 
35–58  years). The median follow-up was 61  months 
(range 15–109  months). The patients’ clinical charac-
teristics associated with the prior surgery are shown in 
Table 1.
The indications for the initial surgery were CIN3 
(n = 5), abnormal uterine bleeding (AUB) (n = 3), uter-
ine prolapse (n =  2), myoma (n =  2), and adenomyosis 
(n = 1). The previous hysterectomy had been performed 
vaginally (n = 2) or by laparotomy (n = 11).
Nine patients were diagnosed with squamous carci-
noma, and four patients had adenocarcinoma. There 
were nine patients with stage IB1 disease and 4fourwith 
stage IA2 disease. Only one patient had deep stromal 
Table 1 Clinicopathologic characteristics of patients with early-stage cervical cancer at the initial operation
CIN cervical intraepithelial neoplasia, AUB abnormal uterine bleeding, TAH total abdominal hysterectomy, LSO left salpingo-oophorectomy, TVH total vaginal 
hysterectomy, SCC squamous cervical cancer, CAC cervical adenocarcinoma, LVSI lymph-vascular space invasion. “+” positive, “−” negative.






Initial surgery pathologic characteristics FIGO 
stage
Histology Depth of  
stromal  
invasion






1 47 CIN3 TAH‑LSO SCC <1/2 − / 12 G2 IB1
2 42 CIN3 TAH SCC <1/2 − 5 / G1 IA2
3 40 AUB TAH SCC <1/2 − 8 / G2 IB1
4 35 CIN3 TAH SCC <1/2 + 7 / G1 IB1
5 55 Uterine prolapse TVH CAC <1/2 + 4 / G3 IA2
6 39 Myoma TAH SCC <1/2 − 7 / G2 IB1
7 41 AUB TAH SCC <1/2 + 9 / G2 IB1
8 37 CIN3 TAH SCC >1/2 − / 30 G2 IB1
9 38 Adenomyosis TAH CAC <1/2 − 6 / G2 IB1
10 37 CIN3 TAH SCC <1/2 + 8 / G3 IB1
11 44 AUB TAH SCC <1/2 − 5 / G1 IA2
12 58 Uterine Prolapse TVH CAC <1/2 − 5 / G2 IA2
13 41 Myoma TAH SCC <1/2 − / 10 G1 IB1
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invasion. Three patients had visible lesions measuring 
10–30 mm, and ten had no visible lesions but invasions 
with depths ranging from 4 to 9 mm. Only four patients 
had LVSI. Four patients had grade 1 disease, seven had 
grade 2 disease, and two had grade 3 disease.
Clinicopathologic characteristics of patients treated 
with RP
The clinicopathologic characteristics of the patients who 
underwent RP are listed in Table  2. Parametrectomy 
was performed a median of 20  days after the prior sur-
gery (range 12–30  days). The mean duration of surgery 
was 242 min (range 200–270 min). The estimated average 
blood loss was 400 mL (range 300–500 mL).
There were two intraoperative complications. One 
patient had an intestinal injury due to pelvic adhesions 
from a previous surgery. An ileal anastomosis was sub-
sequently performed, and the patient recovered well. The 
other patient received a blood transfusion due to preop-
erative anemia and severe intraoperative blood loss.
Two postoperative complications occurred. One 
patient had copious vaginal discharge after the catheter 
was removed. A methylene blue test was performed, and 
the diagnosis of a vesicovaginal fistula was confirmed. A 
repair surgery was successfully conducted 3 months after 
the diagnosis. The other patient had a postoperative ileus 
6 days after the operation and recovered after conserva-
tive treatment.
The catheter was removed a median of 14 days (range 
14–30 days) after RP, and the median residual urine vol-
ume was 100 mL (range 50–250 mL). The median hospi-
tal stay was 16 days (range 14–30 days).
All patients who underwent RP had no residual disease 
found in their radical parametrectomy specimen, and 
only one patient had nodal metastasis. Specimens from 
the previous surgery showed that the tumor size was 
30 mm in diameter and revealed deep stromal invasion. 
The patient received concurrent chemoradiation therapy 
(CCRT) and showed no evidence of recurrence during 
follow-up.
Only one patient (No. 10) experienced recurrence on 
the vaginal cuff during a median follow-up of 61 months 
(range 15–109 months). The initial pathologic diagnosis 
of this patient was poorly differentiated squamous cell 
carcinoma with positive LVSI, which was consistent with 
the diagnosis of the review. The patient was treated with 
whole pelvic radiation and brachytherapy. No further evi-
dence of recurrence was detected during follow-up.
Discussion
Although occult cervical cancer discovered after extra-
fascial hysterectomy for benign indications or pre-inva-
sive cervical cancer is uncommon, the management of 
this cancer is debated. Careful evaluation to exclude cer-
vical malignancy is necessary before performing a simple 
hysterectomy. The evaluation of a benign lesion should 
include a “3-step” screening procedure that includes 
cervical cytology, colposcopy, and biopsy, whereas loop 
excision or conization is strongly recommended for pre-
invasive cervical lesions.
However, due to false negatives, a few patients who 
undergo simple hysterectomy may have occult cervi-
cal cancer even after appropriate preoperative cervical 
evaluation. Extrafascial hysterectomy is not sufficient for 
patients with disease beyond stage IA1 because the sur-
vival rate is less than 50%, whereas the survival rate of 
patients who receive radical surgery or radiation therapy 
is up to 89% [1]. The options for treatment of patients 
with recurrence include: (1) a second surgery with RP, 
upper vaginectomy and pelvic lymphadenectomy, or (2) 
adjuvant radiation. However, due to the limited number 
of cases, no prospective randomized controlled trial has 
compared the efficacy of these two methods. Park et al. 
[16] retrospectively evaluated the outcomes in 99 patients 
with occult cervical cancer who had IA2-IIA lesions. Of 
the 99 patients, 26 received no definitive treatment, 44 
received radiation therapy (RT) or CCRT, and 29 under-
went RP. After a median follow-up of 116  months, the 
recurrence rates were 34.6%, 6.8%, and 0% in the obser-
vation, RT, and RP groups, respectively. Although RP and 
RT/CCRT yielded similar therapeutic efficacy, late com-
plications related to RT were more common and more 
difficult to address than the perioperative complications 
related to RP.
Radical parametrectomy was first described by Dan-
iel and Brunschwig [4]. The procedure is usually per-
formed with an upper vaginectomy and removal of the 
pelvic and/or para-aortic lymph nodes. However, the 
incidence of incidental injury may arise due to destruc-
tion of the normal structure and pelvic adhesions caused 
by the previous surgery. Perioperative complications 
related to RP were reported in approximately 30% of 
patients [8]. Intraoperative blood transfusion, inciden-
tal cystostomy, and postoperative ileus were the most 
common morbidities [7, 8]. Kinney et al. [6] reported 27 
patients who underwent RP. In their study, 24 patients 
(89%) needed an intraoperative blood transfusion and 
2 patients (7%) were diagnosed with a vesicovaginal fis-
tula. Leath et al. [8] reported that 30% of 23 patients had 
operative complications as follows: blood transfusion 
(17%), incidental cystostomy (9%), and postoperative 
ileus (4%). There were four complications in our study, 
including one blood transfusion, one incidental bowel 
injury, one vesicovaginal fistula, and one postoperative 
ileus, which is consistent with the results of literature [7, 
8]. RP may simultaneously remove the residual ligaments 
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and autonomic nerves, which may result in urination 
dysfunction. In our study, 46.2% of the catheters were 
removed more than 14  days after surgery. Adhesions 
from the previous surgery, which increase the risk of 
nerve injury, were likely the main cause of longer pre-
serve time of catheter.
Most surgeons are unwilling to perform RP because 
they consider the RP procedure to be difficult and be 
associated with a high rate of perioperative complica-
tions. Moreover, some surgeons even question the neces-
sity of parametrial resection. In their opinions, not all 
patients with cervical cancer need to undergo a radical 
parametrial resection because the incidence of parame-
trial involvement is not high in early-stage cervical can-
cer, with a rate of 0%–7.7% in stage IA2–IB1 disease [13] 
and 8.4%–10.4% in stage IB1 disease [12, 14, 17]. In recent 
years, many retrospective studies have reported that the 
incidence of parametrial involvement is very low in select 
patients [9–15]. The authors discussed how to identify 
these patients and whether they could be considered can-
didates for less radical surgery such as modified radical 
hysterectomy or extrafascial hysterectomy [8, 15, 18, 19]. 
Kinney et al. [9] studied 387 patients with stage IB1 cervi-
cal cancer and found that the risk of parametrial involve-
ment was 0% in patients with a tumor size smaller than 
2 cm and no LVSI. Stegeman et al. [11] reported on early-
stage cervical cancer with a tumor size <2 cm, infiltration 
depth <10 mm, negative pelvic lymph nodes, and absent 
LVSI and found the risk of parametrial involvement to be 
0.63%. Gemer et al. [15] found that in patients with nega-
tive LVSI, tumor size ≤2 cm, and negative lymph nodes, 
the risk of parametrial involvement was 0.0%. Kodama 
et  al. [14] reviewed 200 stage IB1 cervical cancer cases 
and concluded that in patients with LVSI, an infiltration 
depth <10  mm, and age ≤50  years, the risk of parame-
trial involvement was 0.0%. Wright et  al. [12] reported 
an incidence of parametrial involvement in patients with 
cervical cancer of 10.8%, but in patients with a tumor 
size <2 cm, absent LVSI, and negative lymph nodes, the 
parametrial involvement rate was 0.4%. Covens et al. [10] 
studied 842 patients with early-stage cervical cancer and 
found that in patients with an infiltration depth <10 mm, 
tumor size ≤2 cm, and negative lymph nodes, the risk of 
parametrial involvement was 0.6%. Frumovitz et al. [13] 
studied the incidence of parametrial involvement in 125 
patients with stage IA2–IB1 cervical cancer and found 
that in patients with tumor size ≤2 cm and absent LVSI, 
the incidence was 0.0%. The relationship between the 
parametrial involvement rate and favorable pathologic 
characteristics is listed in Table 3. In our study, there were 
four LVSI-positive patients, one patient with lymph node 
involvement, and one patient with a tumor size >2  cm; 
however, interestingly, there was no parametrial involve-
ment noted, which may be a result of the limited number 
of cases. Only one patient experienced recurrence on the 
vaginal cuff. The pathology was conformed as poorly dif-
ferentiated squamous cell carcinoma with positive LVSI.
Because the incidence of parametrial involvement was 
very low in selected early-stage cervical cancer cases and 
the incidence of complications caused by RP were high, 
the portion of patients who would have benefited from 
RP was low. Triaging patients with a low risk of para-
metrial involvement to omit RP is theoretically feasible. 
Parametrial involvement is associated with tumor size, 
LVSI, and infiltration depth, which may be obtained by 
reevaluating the pathologic specimens from the initial 
surgery. The pelvic lymph node status can be assessed by 
imaging such as MRI, CT, or positron emission tomog-
raphy (PET)-CT before reoperation. A sentinel lymph 
node (SLN) biopsy can also be performed to evaluate the 
pelvic lymph node status and parametrial involvement. 
Strnad et al. [20] studied 158 patients with stage IA2-IB1 
cervical cancer and found that in patients with negative 
SLNs, the incidence of parametrial involvement was 0%, 
suggesting that SLN-negative patients can avoid unneces-
sary RP and even systematic pelvic lymph node resection. 
Table 3 Parametrial involvement rates in patients with early-stage cervical cancer with favorable pathologic characteris-
tics
LVSI lymphovascular space involvement, LN lymph node, N not mentioned. “+” positive, “–” negative.
References No. Stage Low risk criteria Parametrial 
involvement (%)
Tumor size Depth of invasion LVSI LN involvement Age (years)
Gemer et al. [15] 530 IA2–IB1 ≤2 cm N − − N 0
Kodama et al. [14] 200 IB1 N <10 mm − N <50 0
Frumovitz et al. [13] 125 IA2–IB1 ≤2 cm N − N N 0
Stegeman et al. [11] 103 IA2–IB1 <2 cm <10 mm − − N 0.63
Wright et al. [12] 594 IA–IIA <2 cm N − − N 0.4
Covens et al. [10] 842 IA–IB1 ≤2 cm ≤10 mm − − N 0.6
Kinney et al. [9] 387 IB1 <2 cm N − N N 0
Page 6 of 7Lu et al. Chin J Cancer  (2015) 34:37 
Pluta et  al. [19] conducted a pilot study to evaluate the 
feasibility and safety of less radical surgery. Sixty patients 
with stage IA1–IB1 cervical cancer were included in the 
study. Patients were selected based on favorable cervi-
cal tumors (IA1 with LVSI, IA2 and IB1 with tumor size 
<20 mm, and less than 50% stromal invasion). All patients 
underwent laparoscopic SLN identification using frozen 
sections (FS). SLN-negative patients underwent com-
plete pelvic laparoscopic lymphadenectomy and vaginal 
hysterectomy and FS-positive patients underwent radi-
cal hysterectomy with low para-aortic lymphadenectomy. 
There were no recurrences in 55 SLN-negative patients or 
in 5 SLN-positive patients during the follow-up (median 
47 months; range 12–92 months). This preliminary study 
showed that it is both feasible and safe to reduce the radi-
cality of parametrial resection in cases of small tumor 
volume in SLN-negative patients.
The main limitation of our study was an insufficient 
sample size; furthermore, it was not a randomized con-
trolled trial. Thus, our data cannot be used to justify 
omitting RP in selected patients with occult cervical can-
cer after extrafascial hysterectomy.
Conclusions
In summary, although RP is effective in patients with 
occult cervical cancer after extrafascial hysterectomy, 
its surgery-related complications must be considered. 
Our results suggest that a group of patients with very 
low-risk parametrial involvement may benefit from 
omitting RP. Randomized controlled trials are war-
ranted to assess the feasibility and efficacy of extrafas-
cial hysterectomy in patients with low-risk parametrial 
involvement.
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